C. Hackett

Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma

T. Scott, E. Gettings, C. Hackett, 2015, Multiple sclerosis.

Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients

T. Scott, C. Schramke, C. Hackett, 2013, Journal of the Neurological Sciences.

Outcomes in a Modern Cohort of Treated Patients with Multiple Sclerosis from Diagnosis Up to 15 Years.

T. Scott, C. Schramke, T. Hentosz, 2019, International journal of MS care.

Multiple sclerosis relapses contribute to long‐term disability

T. Scott, C. Schramke, E. Gettings, 2019, Acta neurologica Scandinavica.

Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.

T. Scott, C. Schramke, E. Gettings, 2016, Multiple sclerosis and related disorders.

Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression: A predictive model

M. Quigley, T. Scott, C. Schramke, 2014, Clinical Neurology and Neurosurgery.

Safety of venous thromboembolism prophylaxis with fondaparinux in ischemic stroke.

R. Ramanathan, M. Tian, J. Protetch, 2015, Thrombosis research.